期刊
FEBS LETTERS
卷 585, 期 8, 页码 1249-1254出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2011.03.060
关键词
Erythrocyte; Amyloid beta-peptide; Oxidative injury; Phospholipid hydroperoxide; Alzheimer's disease
资金
- JSPS, Japan [20228002]
- Grants-in-Aid for Scientific Research [20228002] Funding Source: KAKEN
The presence of amyloid beta-peptide (A beta) in human blood has recently been established, and it has been hypothesized that A beta readily contacts red blood cells (RBC) and oxidatively impairs RBC functions. In this study, we conducted in vitro and in vivo studies, which provide evidence that A beta induces oxidative injury to RBC by binding to them, causing RBC phospholipid peroxidation and diminishing RBC endogenous carotenoids, especially xanthophylls. This type of damage is likely to injure the vasculature, potentially reducing oxygen delivery to the brain and facilitating Alzheimer's disease (AD). As a preventive strategy, because the A beta-induced RBC damage could be attenuated by treatment of RBC with xanthophylls, we suggest that xanthophylls may contribute to the prevention of AD. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据